Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (321-330 of 423) with videos related to

Pageof 43
Sort By:
Cancer Cell|May 20, 2014
Sumoylation pathway is required to maintain the basal breast cancer subtypeMaria V Bogachek, Yizhen Chen, Mikhail V Kulak, et al.
Annals of Surgical Oncology|July 22, 2018
Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural CommunityAllison W Lorenzen, Boris Kiriazov, James P De Andrade, et al.
Pediatric Blood & Cancer|March 3, 2015
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium reportE Anders Kolb, Valerie Sampson, Deborah Stabley, et al.
Pediatric Blood & Cancer|May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupBrenda J Weigel, Elizabeth Lyden, James R Anderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoLisa A E Harmala, Elizabeth G Ingulli, Julie M Curtsinger, et al.
The American Journal of Cardiology|August 3, 2000
Influence of ventricular morphology on outcome after the Fontan procedureP R Julsrud, T J Weigel, J A Van Son, et al.
Stem Cell Reports|December 6, 2016
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasMaria V Bogachek, Jung M Park, James P De Andrade, et al.
Cancer|November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)James I Geller, Elizabeth Fox, Brian K Turpin, et al.
American Journal of Clinical Oncology|June 30, 2021
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast CancerPhilip M Spanheimer, Amani Bashir, Allison W Lorenzen, et al.
Pageof 43

Showing results (321-330 of 423) with videos related to

Sort By:
Pageof 43
Cancer Cell|May 20, 2014
Sumoylation pathway is required to maintain the basal breast cancer subtypeMaria V Bogachek, Yizhen Chen, Mikhail V Kulak, et al.
Annals of Surgical Oncology|July 22, 2018
Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural CommunityAllison W Lorenzen, Boris Kiriazov, James P De Andrade, et al.
Pediatric Blood & Cancer|March 3, 2015
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium reportE Anders Kolb, Valerie Sampson, Deborah Stabley, et al.
Pediatric Blood & Cancer|May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupBrenda J Weigel, Elizabeth Lyden, James R Anderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoLisa A E Harmala, Elizabeth G Ingulli, Julie M Curtsinger, et al.
The American Journal of Cardiology|August 3, 2000
Influence of ventricular morphology on outcome after the Fontan procedureP R Julsrud, T J Weigel, J A Van Son, et al.
Stem Cell Reports|December 6, 2016
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasMaria V Bogachek, Jung M Park, James P De Andrade, et al.
Cancer|November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)James I Geller, Elizabeth Fox, Brian K Turpin, et al.
American Journal of Clinical Oncology|June 30, 2021
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast CancerPhilip M Spanheimer, Amani Bashir, Allison W Lorenzen, et al.
Pageof 43